BioNTech SE (BNTX) Share-based Compensation Growth (1y) (2020 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 23.70% |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | 11.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.71% |
| Sep 30, 2025 | -27.38% |
| Jun 30, 2025 | 67.04% |
| Mar 31, 2025 | 31.28% |
| Dec 31, 2024 | 64.36% |
| Sep 30, 2024 | 166.21% |
| Jun 30, 2024 | 52.49% |
| Mar 31, 2024 | 91.83% |
| Dec 31, 2023 | -32.54% |
| Sep 30, 2023 | -72.74% |
| Jun 30, 2023 | -9.67% |
| Mar 31, 2023 | -26.57% |
| Dec 31, 2022 | -3.42% |
| Sep 30, 2022 | -15.87% |
| Jun 30, 2022 | -40.39% |
| Mar 31, 2022 | 60,236,874.74% |
| Dec 31, 2021 | 269,441,191.15% |
| Mar 31, 2021 | -100.00% |
| Dec 31, 2020 | -100.00% |